Select a community
All Communities
Home > Community Treatment Reports > Amitiza Treatment Report
What is Amitiza?

Amitza is a brand name for the drug Lubiprostone, a drug used in the treatment of chronic constipation. It works both to soften the stool and initiate bowel movements.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Constipation 21 3
Irritable Bowel Syndrome (IBS) 11 2
Bowel problems 5 1
Other 2 1
General health 2 0
Gastroparesis 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 17%
Mild
1 17%
None
4 67%

Most commonly reported side effects

Nausea/Vomiting
1 17%
Sharp chest pains
1 17%
  • Mild
  • Moderate
  • Severe

Dosages

  2 24mcg as needed 24 mcg weekly 8 mcg daily 16 mcg daily 24 daily 24 mcg daily 48 mcg daily 96 mcg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 11 Number of Patients: 11 15 Number of Patients: 15 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Amitiza (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
4 67% Side effects too severe: 67%
Other
2 33% Other: 33%
Expense
1 17% Expense: 17%
Personal research
1 17% Personal research: 17%

See all 5 patients who’ve stopped taking Amitiza

Currently Taking Amitiza

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
3
4
8
7

Stopped Taking Amitiza

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
1
0
0
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
5 83%
Usually
1 17%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 17%
Somewhat
1 17%
A little
2 33%
Not at all
2 33%

Cost

Paid out of pocket

$200+
0 0%
$100-199
1 17%
$50-99
0 0%
$25-49
0 0%
< $25
2 33%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.